Metabolomics is increasingly being applied towards the identification of biomarkers for disease diagnosis, prognosis and risk prediction. Unfortunately among the many published metabolomic studies ...
SAN FRANCISCO--(BUSINESS WIRE)--Real Chemistry’s IPM.ai, the leader in uncovering undiagnosed and misdiagnosed patients via artificial intelligence (AI) and machine learning (ML), today announced the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback